Detalles de la búsqueda
1.
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer.
N Engl J Med
; 388(1): 33-43, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546651
2.
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
Oncologist
; 28(7): e565-e574, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947993
3.
Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.
Cancer Immunol Immunother
; 72(2): 427-435, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35927359
4.
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Jpn J Clin Oncol
; 53(3): 221-229, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533429
5.
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
BMC Cancer
; 22(1): 711, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35765021
6.
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.
Gastric Cancer
; 25(1): 180-187, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379229
7.
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Future Oncol
; 18(38): 4153-4160, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36475784
8.
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer.
Jpn J Clin Oncol
; 52(10): 1105-1114, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36135357
9.
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study.
Int J Clin Oncol
; 27(7): 1154-1163, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489010
10.
Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602.
Oncologist
; 26(1): 17-e47, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32918848
11.
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Oncologist
; 26(7): e1125-e1132, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977607
12.
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study.
Invest New Drugs
; 39(6): 1649-1655, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34019214
13.
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
BMC Cancer
; 21(1): 518, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33962575
14.
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
Int J Clin Oncol
; 26(7): 1238-1247, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33928486
15.
[Effect of Holistic Patient Support Using the Remote Medication Support Application].
Gan To Kagaku Ryoho
; 48(12): 1497-1501, 2021 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-34911918
16.
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Oncologist
; 25(12): e1855-e1863, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32666647
17.
Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.
BMC Cancer
; 20(1): 1116, 2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203393
18.
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
BMC Cancer
; 20(1): 687, 2020 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32703200
19.
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.
Int J Clin Oncol
; 25(5): 972-977, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31938955
20.
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
Int J Clin Oncol
; 25(10): 1835-1843, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32535711